SCARB1 and lipoprotein glomerulopathy: Moreover, we provide experimental evidence that probucol is protective against SR-B1-associated renal diseases and might be a potential therapeutics for these mutant carriers, although the mechanism by which probucol rescues the atherosclerotic dyslipidemia and LPG-like nephropathy is still uncertain.